We accelerate Down syndrome research to increase availability of therapeutic, diagnostic, and medical care options and we empower families through education, connections, and support.
The Alzheimer’s Association has published an analysis of a 2024 RAND report that outlines the health, community, and economic benefits of more systemic and deliberate investment in the treatment of Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Association has published an analysis of a 2024 RAND report that outlines the health, community, and economic benefits of more systemic and deliberate investment in the treatment of Alzheimer’s disease in adults with Down syndrome.
PCORI funds study of new approach to Sleep Apnea treatment LuMind IDSC will serve as a key partner to researchers from the University of Arizona in an upcoming study of sleep apnea treatment for people with Down syndrome. As part of a $10.4 million award from the Patient-Centered Outcomes Research
LuMind IDSC invites you and your family to become part of the next chapter: for research that will give us answers.
What’s your DS moment?
